WuXi XDC Cayman (HKSE:02268) Accounts Payable : HK$718 Mil (As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is WuXi XDC Cayman Accounts Payable?

WuXi XDC Cayman's Accounts Payable for the quarter that ended in Jun. 2024 was HK$718 Mil.

WuXi XDC Cayman's quarterly Accounts Payable increased from Jun. 2023 (HK$554 Mil) to Dec. 2023 (HK$679 Mil) and increased from Dec. 2023 (HK$679 Mil) to Jun. 2024 (HK$718 Mil).

WuXi XDC Cayman's annual Accounts Payable increased from Dec. 2021 (HK$40 Mil) to Dec. 2022 (HK$537 Mil) and increased from Dec. 2022 (HK$537 Mil) to Dec. 2023 (HK$679 Mil).

WuXi XDC Cayman Accounts Payable Historical Data

The historical data trend for WuXi XDC Cayman's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi XDC Cayman Accounts Payable Chart

WuXi XDC Cayman Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable

5.39

40.15

536.95

678.64

1,089.05

WuXi XDC Cayman Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Accounts Payable	Get a 7-Day Free Trial			536.95	554.20	678.64	717.53	1,089.05

WuXi XDC Cayman Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

WuXi XDC Cayman Accounts Payable Related Terms

Thank you for viewing the detailed overview of WuXi XDC Cayman's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

WuXi XDC Cayman Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » WuXi XDC Cayman Inc (HKSE:02268) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

L74:Germany

Address

No. 11 Xinhui Ring Road, Xinwu, Jiangsu, Wuxi, CHN

Website

https://www.wuxixdc.com

WuXi XDC Cayman Inc is a leading CRDMO focused on the global ADC and broader bioconjugate market and the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, It offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development and manufacturing. The company provides these services from proximately located, state-of-the-art laboratories and manufacturing facilities, leading to the significant reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development and manufacturing platform, its mission is to continuously enhance its platform, and propel and transform the development of the bioconjugate industry.

Executives

Shang Hai He Quan Yao Ye Gu Fen You Xian Gong Si
He Quan Yao Ye Xiang Gang Tou Zi You Xian Gong Si
Shang Hai Yao Ming Kang De Xin Yao Kai Fa You Xian Gong Si
Wu Xi Yao Ming Kang De Xin Yao Kai Fa Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you
Morgan Stanley	2201 Interest of corporation controlled by you
Wuxi Biologics (cayman) Inc.	2101 Beneficial owner
Wuxi Apptec Co., Ltd.

WuXi XDC Cayman Headlines

No Headlines